Waterfront Capital Partners LLC purchased a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 120,112 shares of the real estate investment trust's stock, valued at approximately $10,097,000. National Health Investors accounts for about 1.4% of Waterfront Capital Partners LLC's investment portfolio, making the stock its 25th biggest holding. Waterfront Capital Partners LLC owned approximately 0.26% of National Health Investors as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of NHI. Assetmark Inc. raised its holdings in National Health Investors by 27.8% in the 3rd quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust's stock worth $54,000 after acquiring an additional 141 shares during the period. Aviance Capital Partners LLC increased its stake in shares of National Health Investors by 6.2% in the third quarter. Aviance Capital Partners LLC now owns 3,788 shares of the real estate investment trust's stock worth $318,000 after purchasing an additional 221 shares during the period. Arizona State Retirement System increased its stake in shares of National Health Investors by 1.9% in the second quarter. Arizona State Retirement System now owns 12,152 shares of the real estate investment trust's stock worth $823,000 after purchasing an additional 222 shares during the period. Covestor Ltd lifted its position in shares of National Health Investors by 2,700.0% during the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust's stock worth $35,000 after purchasing an additional 405 shares during the last quarter. Finally, Van ECK Associates Corp grew its holdings in National Health Investors by 6.9% in the 2nd quarter. Van ECK Associates Corp now owns 6,404 shares of the real estate investment trust's stock valued at $434,000 after buying an additional 416 shares during the last quarter. 62.51% of the stock is currently owned by institutional investors and hedge funds.
National Health Investors Price Performance
Shares of NYSE:NHI traded down $0.25 during midday trading on Friday, reaching $76.66. 207,861 shares of the company's stock were exchanged, compared to its average volume of 198,208. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The company's 50 day simple moving average is $78.88 and its two-hundred day simple moving average is $74.69. National Health Investors, Inc. has a 12 month low of $51.59 and a 12 month high of $86.13. The firm has a market capitalization of $3.48 billion, a PE ratio of 26.71, a price-to-earnings-growth ratio of 5.13 and a beta of 1.05.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. During the same quarter in the prior year, the business earned $1.08 EPS. The firm's revenue for the quarter was up 1.7% on a year-over-year basis. Equities research analysts expect that National Health Investors, Inc. will post 4.42 earnings per share for the current fiscal year.
National Health Investors Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 4.70%. The ex-dividend date is Tuesday, December 31st. National Health Investors's dividend payout ratio (DPR) is 123.71%.
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the company. Truist Financial upped their price target on National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a report on Friday, August 30th. Bank of America initiated coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price target for the company. StockNews.com downgraded shares of National Health Investors from a "buy" rating to a "hold" rating in a report on Tuesday, October 15th. Finally, Wells Fargo & Company cut shares of National Health Investors from an "overweight" rating to an "equal weight" rating and increased their target price for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $76.33.
Check Out Our Latest Research Report on NHI
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.